APA (7th ed.) Citation

SP, H., AX, Z., & Y, W. (2020). Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities. Frontiers in immunology, 11, 598877. https://doi.org/10.3389/fimmu.2020.598877

Chicago Style (17th ed.) Citation

SP, Hack, Zhu AX, and Wang Y. "Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities." Frontiers in Immunology 11 (2020): 598877. https://doi.org/10.3389/fimmu.2020.598877.

MLA (9th ed.) Citation

SP, Hack, et al. "Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities." Frontiers in Immunology, vol. 11, 2020, p. 598877, https://doi.org/10.3389/fimmu.2020.598877.